Clinical Trial Update: Hypo-fractionated Postoperative IMRT in Prostate Cancer [NA]

View source ↗

Summary

A completed clinical trial evaluating hypo-fractionated postoperative intensity-modulated radiotherapy (IMRT) for prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: Prostate Cancer | NA | Status: COMPLETED